Výsledky vyhledávání - "van Moorselaar, R J A"

Pneumothorax als vroege aanwijzing voor een erfelijke aandoening

Autor: van Riel, Lore, van de Beek, Irma, Wolthuis, Rob M. F., Boerrigter, Bart G., van Moorselaar, R. J. A., Houweling, Arjan C.

Publikováno v: van Riel, L, van de Beek, I, Wolthuis, R M F, Boerrigter, B G, van Moorselaar, R J A & Houweling, A C 2023, ' Pneumothorax als vroege aanwijzing voor een erfelijke aandoening ', Nederlands Tijdschrift voor Geneeskunde, vol. 167 .

BACKGROUND: Several hereditary disorders, with highly variable and sometimes difficult to recognize manifestations, can present with a spontaneous pneumothorax. Options to perform DNA-testing have changed rapidly, as a result of which physicians of d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::232d93e9bb0c1457db891e1d799f20a9
https://research.vumc.nl/en/publications/ab7a40ac-7310-4e3e-8132-cb8e2f34b7ad

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study.

Autor: Yildirim, H., Schuurman, M. S., Widdershoven, C. V., Lagerveld, B. W., van den Brink, L., Ruiter, A. E. C., Beerlage, H. P., van Moorselaar, R. J. A., Graafland, N. M., Bex, A., Aben, K. K. H., Zondervan, P. J.

Publikováno v: BJUI Compass; Jul2023, Vol. 4 Issue 4, p455-463, 9p

Zobrazit plný text záznamu

Corrigendum to 'Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study' (Urologic Oncology: Seminars and Original Investigations (2020) 38(9) (735.e17–735.e25), (S1078143920302519), (10.1016/j.urolonc.2020.05.022))

Autor: Vernooij, R. W. M., Cremers, R. G. H. M., Jansen, H., Somford, D. M., Kiemeney, L. A., van Andel, G., Wijsman, B. P., Busstra, M. B., van Moorselaar, R. J. A., Wijnen, E. M., Pos, F. J., Hulshof, M. C. C. M., Hamberg, P., van den Berkmortel, F., Hulsbergen-van de Kaa, C. A., van Leenders, G. J. L. H., F€utterer, J. J., van Oort, I. M., Aben, K. K. H.

Publikováno v: Urologic Oncology: Seminars and Original Investigations, 40(7). Elsevier Inc.
Vernooij, R W M, Cremers, R G H M, Jansen, H, Somford, D M, Kiemeney, L A, van Andel, G, Wijsman, B P, Busstra, M B, van Moorselaar, R J A, Wijnen, E M, Pos, F J, Hulshof, M C C M, Hamberg, P, van den Berkmortel, F, Hulsbergen-van de Kaa, C A, van Leenders, G J L H, F€utterer, J J, van Oort, I M & Aben, K K H 2022, ' Corrigendum to “Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer : A nationwide observational study” (Urologic Oncology: Seminars and Original Investigations (2020) 38(9) (735.e17–735.e25), (S1078143920302519), (10.1016/j.urolonc.2020.05.022)) ', Urologic Oncology: Seminars and Original Investigations, vol. 40, no. 7, pp. 353 . https://doi.org/10.1016/j.urolonc.2022.05.007
Urologic oncology, 40(7). Elsevier Inc.

The authors regret that the following statements were incorrectly mentioned in the paper. Page 4, line 333, paragraph 3.1. Descriptive statistics: “.2358.” should be 2538 Page 4, line 338-340, paragraph 3.1. Descriptive statistics: “.and were t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5db9ac6c33daac385d9187bc05ef619d
https://research.vumc.nl/en/publications/7bf2f294-6884-4306-b65e-14f0de58c5d3

Zobrazit plný text záznamu

Additional file 1 of Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial

Autor: Janssen, J., Staal, F. H. E., Brouwer, C. L., Langendijk, J. A., de Jong, I. J., van Moorselaar, R. J. A., Schuit, E., Verzijlbergen, J. F., Smeenk, R. J., Aluwini, S.

Additional file 1. Target volume definitions and dose to organs at risk.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0516518e52a20a6bf14ab806c6ee6bfb

Zobrazit plný text záznamu

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial

Autor: Janssen, J, Staal, F H E, Brouwer, C L, Langendijk, J A, de Jong, I J, van Moorselaar, R J A, Schuit, E, Verzijlbergen, J F, Smeenk, R J, Aluwini, S

Publikováno v: BMC Cancer, 22
BMC Cancer, 22(1):482. BioMed Central
BMC Cancer, 22, 1
Janssen, J, Staal, F H E, Brouwer, C L, Langendijk, J A, de Jong, I J, van Moorselaar, R J A, Schuit, E, Verzijlbergen, J F, Smeenk, R J & Aluwini, S 2022, ' Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT) : study protocol for a randomised phase III trial ', BMC Cancer, vol. 22, no. 1, 482 . https://doi.org/10.1186/s12885-022-09523-2
BMC Cancer, 22(1):482. BMC

Background More than 60% of oligo-recurrent prostate cancer (PCa) patients treated with metastasis-directed radiotherapy (MDRT) develop biochemical recurrence within 2 years. This recurrence rate emphasises the need for improved treatment and patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66d2a1590219078a953368fea083c2ad
http://hdl.handle.net/2066/250165

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání